
[/caption]
seborrheic keratosis icd 10
BURLINGAME, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc., (Nasdaq: PLSE) a medical technology aggregation developing a proprietary ameliorative tissue analysis belvedere based on Nano-Pulse Stimulation (NPS), will host its annual broker appointment alarm on July 27, 2017, at 1:30 p.m. PDT / 4:30 p.m. EDT. The aggregation will accommodate an amend on the analytic advance of the PulseTxTM System, including advance of the analytic abstraction evaluating NPS for the analysis of seborrheic keratosis (SK), as able-bodied as the cachet of the 510(k) acquiescence from beforehand this year. The aggregation will additionally accommodate an amend on contempo banking after-effects and developments, including banking after-effects for the division concluded June 30, 2017.
Conference Alarm Details
Pulse Biosciences’ Darrin Uecker, President and Chief Executive Officer, and added chief admiral will host the broker alarm on July 27, 2017, at 1:30 p.m. PDT / 4:30 p.m. EDT. For both “listen-only” participants and those who ambition to booty allotment in the catechism and acknowledgment allocation of the call, the blast dial-in cardinal is (844) 494-0190 (U.S. toll-free) or (508) 637-5580 (international) application Appointment ID 52323044. Listeners will additionally be able to admission the alarm via webcast accessible on the Broker Section of the company’s website at www.pulsebiosciences.com.
About Pulse Biosciences
Pulse Biosciences is a medical technology aggregation developing a ameliorative tissue analysis belvedere based on Nano-Pulse Stimulation (NPS), a proprietary corpuscle signaling technology. NPS is a non-thermal, precise, focal drug-free tissue analysis technology that anon affects the corpuscle film and intracellular structures to activate different behaviors in cells. NPS can admit a corpuscle afterlife action that allows for the analysis of tissue beef with basal anarchic acknowledgment which improves healing outcomes and supports the backup of advised tissue beef with advantageous tissue cells. In annihilative lesions, NPS has been apparent in preclinical models to abet immunogenic corpuscle afterlife (ICD) advertisement the different antigens of the advised beef to the allowed system, consistent in the bearing of cytotoxic T-cells and the ascent of an adaptive allowed acknowledgment targeted adjoin those cells. Pulse Biosciences is investigating a array of applications for its technology that exploits the technology’s different biologic effect, including immuno-oncology, dermatology, and veterinary medicine. More advice is accessible at www.pulsebiosciences.com.
[caption id="" align="aligncenter" width="300"]

[/caption]
[caption id="" align="aligncenter" width="400"]

[/caption]
[caption id="" align="aligncenter" width="513"]

[/caption]
[caption id="" align="aligncenter" width="325"]
[/caption]
[caption id="" align="aligncenter" width="400"]

[/caption]
[caption id="" align="aligncenter" width="1280"]
[/caption]
[caption id="" align="aligncenter" width="400"]

[/caption]
[caption id="" align="aligncenter" width="400"]

[/caption]
[caption id="" align="aligncenter" width="400"]

[/caption]
[caption id="" align="aligncenter" width="400"]

[/caption]